Thyrocare Technologies Ltd. is in Hospital & Healthcare Services. It was incorporated in year 2000. The current market capitalisation stands Rs 2494 Cr. The company is listed on the Bombay Stock Exchange (BSE) with the BSE code as 539871. and also listed on National Stock Exchange (NSE) with NSE code as THYROCARE.
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. The operates through Pathology, Radiology, and Sale of Testing Equipment and Consumables segments. It conducts medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility, and various infectious diseases. Its profiles of tests include 15 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The also provides PET-CT scan imaging diagnostic services. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India.
Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.
Past performance is not indicative of future returns. Please consider your specific investment requirements, risk tolerance, investment goal, time frame, risk and reward balance and the cost associated with the investment before choosing a fund, or designing a portfolio that suits your needs.